160 related articles for article (PubMed ID: 8096741)
21. The treatment of osteogenic sarcoma.
Brown KL
Can J Surg; 1986 Jan; 29(1):5-6. PubMed ID: 3455675
[No Abstract] [Full Text] [Related]
22. [Therapeutic orientation in osteogenic sarcomas].
Trifaud A
Rev Chir Orthop Reparatrice Appar Mot; 1974; 60(7):517-30. PubMed ID: 4282165
[No Abstract] [Full Text] [Related]
23. Significant recent advances in the treatment of osteogenic sarcoma.
Cohen IJ
Isr J Med Sci; 1993 Nov; 29(11):748-53. PubMed ID: 8270413
[No Abstract] [Full Text] [Related]
24. Osteosarcoma.
Campanacci M; Ruggieri P
Bull Hosp Jt Dis Orthop Inst; 1991; 51(1):1-11. PubMed ID: 1652313
[TBL] [Abstract][Full Text] [Related]
25. Adjuvant Sirolimus Does Not Improve Outcome in Pet Dogs Receiving Standard-of-Care Therapy for Appendicular Osteosarcoma: A Prospective, Randomized Trial of 324 Dogs.
LeBlanc AK; Mazcko CN; Cherukuri A; Berger EP; Kisseberth WC; Brown ME; Lana SE; Weishaar K; Flesner BK; Bryan JN; Vail DM; Burton JH; Willcox JL; Mutsaers AJ; Woods JP; Northrup NC; Saba C; Curran KM; Leeper H; Wilson-Robles H; Wustefeld-Janssens BG; Lindley S; Smith AN; Dervisis N; Klahn S; Higginbotham ML; Wouda RM; Krick E; Mahoney JA; London CA; Barber LG; Balkman CE; McCleary-Wheeler AL; Suter SE; Martin O; Borgatti A; Burgess K; Childress MO; Fidel JL; Allstadt SD; Gustafson DL; Selmic LE; Khanna C; Fan TM
Clin Cancer Res; 2021 Jun; 27(11):3005-3016. PubMed ID: 33753454
[TBL] [Abstract][Full Text] [Related]
26. [Current approaches to the combination therapy of osteogenic sarcoma].
Trapeznikov NN; Eremina LA; Imamaliev AS; Amiraslanov AT; Kondrat'ev VG
Vopr Onkol; 1981; 27(8):12-8. PubMed ID: 6944949
[TBL] [Abstract][Full Text] [Related]
27. IIB osteosarcoma. Current management, local control, and survival statistics--The Netherlands.
Veth RP
Clin Orthop Relat Res; 1991 Sep; (270):67-71. PubMed ID: 1884561
[TBL] [Abstract][Full Text] [Related]
28. Outcome after local recurrence of osteosarcoma: the St. Jude Children's Research Hospital experience (1970-2000).
Rodriguez-Galindo C; Shah N; McCarville MB; Billups CA; Neel MN; Rao BN; Daw NC
Cancer; 2004 May; 100(9):1928-35. PubMed ID: 15112274
[TBL] [Abstract][Full Text] [Related]
29. Editorial: New therapies for osteogenic sarcoma.
Campbell CJ; Cohen J; Enneking WF
J Bone Joint Surg Am; 1975 Mar; 57(2):143-4. PubMed ID: 1054022
[No Abstract] [Full Text] [Related]
30. Intraarterial cisplatin in the management of stage IIB osteosarcoma in the pediatric and adolescent age group.
Jaffe N; Smith D; Jaffe MR; Hudson M; Carrasco H; Wallace S; Raymond AK; Ayala A; Murray J; Robertson R
Clin Orthop Relat Res; 1991 Sep; (270):15-21. PubMed ID: 1884535
[TBL] [Abstract][Full Text] [Related]
31. A virally induced osteosarcoma in rats. A model for immunological studies of human osteosarcoma.
Friedlaender GE; Mitchell MS
J Bone Joint Surg Am; 1976 Apr; 58(3):295-302. PubMed ID: 1063126
[TBL] [Abstract][Full Text] [Related]
32. [Therapy and prognosis in osteosarcoma: changing thoughts and numbers].
Campanacci M
Chir Organi Mov; 1984; 69(1):7-9. PubMed ID: 6593179
[No Abstract] [Full Text] [Related]
33. Analysis of prognostic factors in 333 Chinese patients with high-grade osteosarcoma treated by multidisciplinary combined therapy.
Min D; Lin F; Shen Z; Zheng S; Tan L; Yu W; Yao Y
Asia Pac J Clin Oncol; 2013 Mar; 9(1):71-9. PubMed ID: 22897971
[TBL] [Abstract][Full Text] [Related]
34. [Analysis of the up-to-date methods of treating children with osteosarcoma].
Woźniak W; Kozera-Pawlukiewicz M; Dembowska-Bagińska B
Chir Narzadow Ruchu Ortop Pol; 1988; 53(4):318-21. PubMed ID: 3254271
[No Abstract] [Full Text] [Related]
35. The role of surgery and adjuvants to survival in Pagetic osteosarcoma.
Ruggieri P; Calabrò T; Montalti M; Mercuri M
Clin Orthop Relat Res; 2010 Nov; 468(11):2962-8. PubMed ID: 20652460
[TBL] [Abstract][Full Text] [Related]
36. Age and Tumor Location Predict Survival in Nonmetastatic Osteosarcoma in Upper Egypt.
Morsy AM; Ahmed BM; Rezk KM; Ramadan IK; Aboelgheit AM; Eltyb HA; Abd Elbadee OM; El-Naggar MS
J Pediatr Hematol Oncol; 2020 Mar; 42(2):e66-e78. PubMed ID: 31107367
[TBL] [Abstract][Full Text] [Related]
37. Progress and opportunities for immune therapeutics in osteosarcoma.
Lettieri CK; Appel N; Labban N; Lussier DM; Blattman JN; Hingorani P
Immunotherapy; 2016 Oct; 8(10):1233-44. PubMed ID: 27605071
[TBL] [Abstract][Full Text] [Related]
38. Activation of TLR4 signaling inhibits progression of osteosarcoma by stimulating CD8-positive cytotoxic lymphocytes.
Yahiro K; Matsumoto Y; Yamada H; Endo M; Setsu N; Fujiwara T; Nakagawa M; Kimura A; Shimada E; Okada S; Oda Y; Nakashima Y
Cancer Immunol Immunother; 2020 May; 69(5):745-758. PubMed ID: 32047957
[TBL] [Abstract][Full Text] [Related]
39. Multidisciplinary "limb salvage" treatment of osteosarcoma.
Pochanugool L; Nontasut S; Subhadharaphandou T; Hathirat P; Sirikulchayanonta V; Ratanatharathorn V; Yuktanonda P
J Med Assoc Thai; 1991 Sep; 74(9):404-11. PubMed ID: 1791395
[TBL] [Abstract][Full Text] [Related]
40. Management of osteogenic sarcoma: a perspective based on the Mayo Clinic experience.
Gilchrist GS; Pritchard DJ; Dahlin DC; Ivins JC; Taylor WF; Edmonson JH
Natl Cancer Inst Monogr; 1981 Apr; (56):193-9. PubMed ID: 6946290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
